Breaking News, Collaborations & Alliances

CDMO List Labs Partners with Genome & Company

Creates global microbiome research, development and manufacturing powerhouse.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Microbiome contract development and manufacturing organization (CDMO) List Labs has partnered with the global clinical stage biotechnology company, Genome & Company. Republic of South Korea based Genome & Company has entered into agreements subject to regulatory approval to acquire controlling interest in U.S. based List Biological Laboratories, Inc. (List Labs). The resulting partnership creates the first global live biotherapeutic drug development company with integrated contract devel...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters